Is there a role for SARS-CoV-2 antigen testing in the post-containment strategy?

被引:0
|
作者
Brochot, Etienne [1 ,2 ]
机构
[1] Amiens Univ, Dept Virol, Med Ctr, Amiens, France
[2] Jules Verne Univ Picardie, UR4294, Unite Rech Agents Infect Resistance & Chimiothera, Amiens, France
来源
JOURNAL OF CLINICAL VIROLOGY PLUS | 2021年 / 1卷 / 1-2期
关键词
SARS-CoV-2; COVID-19; PCR assays; Performance assays;
D O I
10.1016/j.jcvp.2021.100009
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: With the availability and widespread deployment of antigenic tests for SARS-CoV-2 during the second epidemic wave in Europe, the performance of such tests in real-life situations is beginning to become available. Objectives: The question of the role of these tests during periods of low circulation of the virus has been legitimately raised. Study design: We addressed this question by analyzing the results of more than 16,000 SARS-CoV-2 PCRs during the first half of 2020 in a French region heavily affected by COVID-19. We were thus able to calculate and extrapolate the theoretical sensitivity of the antigenic tests for various periods during and after the first epidemic wave. Results: As the PCR-positivity rate of nasopharyngeal swabs declined over time, the proportion of samples with low Ct levels also decreased. Thus, the calculation of the analytical sensitivity of the antigenic tests ranged from 70 to 80% when the percentage of PCR positivity was > 1%, but fell below this score when it was lower. Conclusions: The performance and relevance of antigenic tests appears to be more limited during phases of low circulation of the virus. This may have a negative impact on the effectiveness of isolation, testing, and contact tracing strategies.
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Optimal group testing strategy for the mass screening of SARS-CoV-2
    Huang, Fengfeng
    Guo, Pengfei
    Wang, Yulan
    OMEGA-INTERNATIONAL JOURNAL OF MANAGEMENT SCIENCE, 2022, 112
  • [22] A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
    Leon Mutesa
    Pacifique Ndishimye
    Yvan Butera
    Jacob Souopgui
    Annette Uwineza
    Robert Rutayisire
    Ella Larissa Ndoricimpaye
    Emile Musoni
    Nadine Rujeni
    Thierry Nyatanyi
    Edouard Ntagwabira
    Muhammed Semakula
    Clarisse Musanabaganwa
    Daniel Nyamwasa
    Maurice Ndashimye
    Eva Ujeneza
    Ivan Emile Mwikarago
    Claude Mambo Muvunyi
    Jean Baptiste Mazarati
    Sabin Nsanzimana
    Neil Turok
    Wilfred Ndifon
    Nature, 2021, 589 : 276 - 280
  • [23] Testing for SARS-CoV-2 antibodies
    Watson, Jessica
    Richter, Alex
    Deeks, Jonathan
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [24] Testing animals for SARS-CoV-2
    Middlemiss, Christine
    Glossop, Christianne
    Voas, Sheila
    Huey, Robert
    VETERINARY RECORD, 2020, 186 (17)
  • [25] Diagnostic testing for SARS-CoV-2
    Boodman, Carl
    Lagace-Wiens, Philippe
    Bullard, Jared
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (26) : E713 - E713
  • [26] Diagnostic testing for SARS-CoV-2
    Boodman, Carl
    Lagace-Wiens, Philippe
    Bullard, Jared
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (47) : E1608 - E1608
  • [27] Testing for antibodies to SARS-CoV-2
    Gill, Dipender
    Ponsford, Mark J.
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 371
  • [28] A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study
    Yokota, Isao
    Shane, Peter Y.
    Okada, Kazufumi
    Unoki, Yoko
    Yang, Yichi
    Iwasaki, Sumio
    Fujisawa, Shinichi
    Nishida, Mutsumi
    Teshima, Takanori
    LANCET MICROBE, 2021, 2 (08): : E397 - E404
  • [29] Factors that Influence the Reported Sensitivity of Rapid Antigen Testing for SARS-CoV-2
    Parvu, Valentin
    Gary, Devin S.
    Mann, Joseph
    Lin, Yu-Chih
    Mills, Dorsey
    Cooper, Lauren
    Andrews, Jeffrey C.
    Manabe, Yukari C.
    Pekosz, Andrew
    Cooper, Charles K.
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [30] Review of SARS-CoV-2 Antigen and Antibody Testing in Diagnosis and Community Surveillance
    Nerenz, Robert D.
    Hubbard, Jacqueline A.
    Cervinski, Mark A.
    CLINICS IN LABORATORY MEDICINE, 2022, 42 (04) : 687 - 704